Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2022

View Archived Issues

New free fatty acid receptor 1 agonists identified at Rezubio Pharmaceuticals

Shanghai Zheye Biotechnology describes new anticancer compounds

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Apoptosis regulator Bcl-2 inhibitors discovered at Beijing Innocare Medical Technology

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Mouse model of SARS-CoV-2 infection shows COVID-19-like disease is dependent on ACE2

STING signaling in beta cells maintains glucose homeostasis

Type II interferon restricts severity of NMO in a new preclinical model

Bryostatin-1 promotes regenerative phenotype within microglia and CNS macrophages

Novel murine model developed to test CNS-penetrant BTK inhibitors

BAFF biomarker tied to severity of allergic rhinitis

Shionogi and Ube collaborate to advance S-337395 toward clinic for RSV

Study identifies potential new bone disease target

Murine model reveals aging to promote autoimmune encephalomyelitis with meningeal inflammation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...